Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
3-methylglutaconic aciduria type 8
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
07/11/2022
Evidence/Notes:

HTRA2 was first reported in relation to autosomal recessive 3-methylglutaconic aciduria type 8 in 2016 (Mandel H, et al., 2016, PMID: 27208207). HTRA2 encodes an ATP-independent serine protease that resides in the mitochondrial intermembrane space, but upon cellular stress, HTRA2 is processed to a shorter form and released into the cytosol. Here, it facilitates cell death through cleavage of apoptosis inhibitor proteins. Mutations in the gene lead to increased susceptibility to apoptosis and neurodegeneration. The clinical features include hypotonia, dystonia, seizures and cardio-respiratory difficulties. Urine analysis characteristically shows excretion of 3-methylglutaconic acid. Eight variants (missense, indel, frameshift, and splice variants) have been reported in 7 probands (and 3 family members) from 4 publications (PMIDs: 27208207, 27696117, 30114719, and 32445293). This gene-disease association is also supported by its biochemical functions in proteolytic cleavage and apoptosis (PMID: 11604410), which are altered in patient cells (PMIDs: 27696117. 27208207). As well two mouse models that recapitulate to the human phenotype (PMIDs: 15509788, 14534547). In summary, HTRA2 is definitively associated with autosomal recessive 3-methylglutaconic aciduria type 8.

PubMed IDs:
11604410 14534547 15509788 27208207 27696117 30114719 32445293
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.